No Data
No Data
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), Avinger (AVGR) and GlycoMimetics (GLYC)
GlycoMimetics | 10-Q: Q2 2024 Earnings Report
GlycoMimetics Announces Strategic Review and Restructuring Plan
Express News | GlycoMimetics Anticipates Recognizing About $3.6M In Total Charges In Connection With Headcount Reduction, A Restructuring That Includes A Reduction In Company's Workforce By 26 Employees, Or ~80% Of Its Headcount
Express News | GlycoMimetics Inc - Employment of Edwin Rock, Co's Chief Medical Officer, Will End on July 31, 2024